Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation
Guanrui Liao(Beth Israel Deaconess Medical Center), Sizun Jiang(Cambridge Hospital), Angela Yang(Stanford University), Dawn T. Bravo(Stanford University), David Zarabanda(Stanford University), Nicole A. Borchard(Stanford University), Bokai Zhu(Broad Institute), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Jonathan B. Overdevest(Columbia University Irving Medical Center), Qin Ma(The Ohio State University), John A. Coller(Stanford University), Dingani Nkosi(Brigham and Women's Hospital), Garry P. Nolan(Stanford University), Katie M. Phillips(University of Cincinnati), Te‐Huei Yeh(National Taiwan University Hospital), Ivan T. Lee, Maria Serena Longhi(Beth Israel Deaconess Medical Center), Tsuguhisa Nakayama(Stanford University), Cankun Wang(The Ohio State University), Dan H. Barouch(Beth Israel Deaconess Medical Center), Axel E. Renteria(Centre Hospitalier de l’Université de Montréal), Dhananjay Wagh(University of Würzburg), Jayakar V. Nayak(Stanford University), Carol H. Yan(University of California San Diego), Chun‐Kang Liao(National Yunlin University of Science and Technology), Sachi S. Dholakia(Stanford University), Jason Yeung(Beth Israel Deaconess Medical Center), Peter H. Hwang(Stanford University), Yuzhou Chang(Shanghai Institute of Measurement and Testing Technology), Yao Yu Yeo(Beth Israel Deaconess Medical Center), Philip A. Gall(Stanford University), Michael T. Chang(Stanford University), Zara M. Patel(Stanford University), Zihai Li(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Dayoung Kim(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Matt Lechner(University College London)
Cited by 16
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k